» Articles » PMID: 32066745

A Co-culture Nanofibre Scaffold Model of Neural Cell Degeneration in Relevance to Parkinson's Disease

Overview
Journal Sci Rep
Specialty Science
Date 2020 Feb 19
PMID 32066745
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Current therapeutic strategies for Parkinson's disease (PD) aim to delay progression or replace damaged neurons by restoring the original neuronal structures. The poor regenerative capacity of neural tissue highlights the need for the development of cellular environments to model the pathogenesis of PD. In the current work, we have characterised the growth, survival and response to PD mimetics of human SH-SY5Y neuroblastoma and U-87MG glioblastoma cell lines cultured on polyacrylonitrile (PAN) and Jeffamine® doped polyacrylonitrile (PJ) nano-scaffolds. Differentiation induced by a range of agents was evaluated by immunoassays of neural protein biomarkers. PAN and PJ nanofibre scaffolds provided suitable three-dimensional (3D) environment to support the growth, differentiation and network formation of dopaminergic neuron- and astrocyte-like cell populations, respectively. The scaffolds selectively supported the survival and differentiation of both cell populations with prolonged neuronal survival when exposed to PD mimetics in the presence of astrocytes in a co-culture model. Such 3D nanoscaffold-based assays could aid our understanding of the molecular basis of PD mimetic-induced Parkinsonism and the discovery of neuroprotective agents.

Citing Articles

Co-Culture Models: Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling Studies.

Monteiro A, Barbosa D, Remiao F, Silva R Biomedicines. 2024; 12(3).

PMID: 38540242 PMC: 10967866. DOI: 10.3390/biomedicines12030626.


Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases.

Balestri W, Sharma R, da Silva V, Bobotis B, Curle A, Kothakota V J Neuroinflammation. 2024; 21(1):32.

PMID: 38263227 PMC: 10807115. DOI: 10.1186/s12974-024-03024-8.


Advanced 3D Models of Human Brain Tissue Using Neural Cell Lines: State-of-the-Art and Future Prospects.

Fabbri R, Cacopardo L, Ahluwalia A, Magliaro C Cells. 2023; 12(8).

PMID: 37190089 PMC: 10136913. DOI: 10.3390/cells12081181.


Biomaterials to enhance stem cell transplantation.

Kharbikar B, Mohindra P, Desai T Cell Stem Cell. 2022; 29(5):692-721.

PMID: 35483364 PMC: 10169090. DOI: 10.1016/j.stem.2022.04.002.


Synthesis and Functionalisation of Superparamagnetic Nano-Rods towards the Treatment of Glioblastoma Brain Tumours.

Habra K, McArdle S, Morris R, Cave G Nanomaterials (Basel). 2021; 11(9).

PMID: 34578472 PMC: 8472662. DOI: 10.3390/nano11092157.


References
1.
Davie C . A review of Parkinson's disease. Br Med Bull. 2008; 86:109-27. DOI: 10.1093/bmb/ldn013. View

2.
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, SEITELBERGER F . Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973; 20(4):415-55. DOI: 10.1016/0022-510x(73)90175-5. View

3.
Lindvall O, Kokaia Z . Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci. 2009; 30(5):260-7. DOI: 10.1016/j.tips.2009.03.001. View

4.
Pla A, Pascual M, Guerri C . Autophagy Constitutes a Protective Mechanism against Ethanol Toxicity in Mouse Astrocytes and Neurons. PLoS One. 2016; 11(4):e0153097. PMC: 4829237. DOI: 10.1371/journal.pone.0153097. View

5.
Hass D, Barnstable C . Uncoupling protein 2 in the glial response to stress: implications for neuroprotection. Neural Regen Res. 2016; 11(8):1197-200. PMC: 5020804. DOI: 10.4103/1673-5374.189159. View